home / stock / cydy / cydy news

CYDY News and Press, CytoDyn Inc From 05/13/21

Stock Information
Company Name: CytoDyn Inc
Stock Symbol: CYDY
Market: OTC
Website: cytodyn.com
Menu
CYDY CYDY Quote CYDY Short CYDY News CYDY Articles CYDY Message Board
Get CYDY Alerts

News, Short Squeeze, Breakout and More Instantly...
CYDY - CytoDyn inks leronlimab distribution deal in India for COVID-19

CytoDyn (CYDY) has executed an exclusive supply and distribution agreement with Macleods Pharmaceuticals in India.This commercial agreement will enable Macleods to sell leronlimab in India following regulatory clearance. “We believe there is an immediate need for leronlimab i...
CYDY - CytoDyn Signs Distribution Agreement with Macleods Pharmaceuticals Ltd. to Pursue EUA and Compassionate Use Access to Leronlimab in India

Macleods is one of the largest pharmaceutical companies in India with presence in over 140 countries VANCOUVER, Washington, May 13, 2021 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY) , (“CytoDyn” or the “Company"), a late-stage biotechnology company develo...

CYDY - CytoDyn's Leronlimab Featured on OneNews in Philippines on May 9

Drs. Pourhassan, Recknor, Seethamraju and Nicolas will appear in a one-hour segment beginning at 5:00 pm PT / 8:00 pm ET, Sunday, May 9 VANCOUVER, Washington, May 07, 2021 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY) , (“CytoDyn” or the “Company"), a la...

CYDY - CytoDyn: Suitable For Trading Not Investing

In 2019, CytoDyn touted initial approval of leronlimab as a blockbuster combination therapy for HIV. CytoDyn has encountered a long string of obstacles in presenting leronlimab to the FDA for its consideration. Leronlimab's current status in its quest for approval as combination t...
CYDY - CytoDyn to conduct two COVID-19 trials in Brazil

CytoDyn (CYDY) announces an agreement to partner with Academic Research Organization - Albert Einstein Israelite Hospital in São Paulo, Brazil for two COVID-19 trials. The COVID-19 trials in Brazil are intended to provide the regulatory authority, ANVISA, with the requisite data to consi...

CYDY - CytoDyn Reaches Agreement with Albert Einstein Israelite Hospital in Brazil to Conduct Two COVID-19 Trials - a Small Trial in Critically Ill and a Large Trial in Severe Populations

Interim analysis for critically ill population will be conducted when enrollment reaches about 120 patients or 40% of the approximate 300 patients VANCOUVER, Washington, May 05, 2021 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY) , (“CytoDyn” or the “Comp...

CYDY - CytoDyn provides updates on leronlimab HIV extension arm; to hold webcast on May 5 on multiple initiatives

CytoDyn (CYDY) announces a comprehensive update on three continuing extension studies with leronlimab as a treatment for HIV. Clinical results from multiple trials show that Vyrologix can significantly reduce the viral burden in people infected with HIV.Moreover, a Phase 2 trial demonstrated ...
CYDY - CytoDyn to Hold Webcast on May 5 to Provide Update on Multiple Initiatives

VANCOUVER, Washington, May 03, 2021 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY) , (“CytoDyn” or the “Company"), a late-stage biotechnology company developing Vyrologix™ (leronlimab-PRO 140), a CCR5 antagonist with the potential for multiple therapeutic in...

CYDY - Data from 10 Patients with Stage Four Cancer Treated with Leronlimab for Nearly One Year Will Serve as Basis for Pre-Breakthrough Therapy Designation Meeting with FDA

VANCOUVER, Washington, May 03, 2021 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY) , (“CytoDyn” or the “Company"), a late-stage biotechnology company developing leronlimab (Vyrologix or PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indicat...

CYDY - CytoDyn HIV Indication Update: Leronlimab HIV Extension Arm Nearing 7 Years with Continued Excellent Safety Results

Following the successful conclusion of three clinical trials, approximately 120 patients continue treatment with leronlimab in extension arms VANCOUVER, Washington, May 03, 2021 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY) , (“CytoDyn” or the “Company")...
Previous 10 Next 10